John Gallacher

“During the project, the partners will involve diverse stakeholders (patients, carers, regulators, HTA bodies, payers, industry and researchers) to identify and prioritise possible outcomes of clinical trials with regard to their individual relevance but also health-economic importance. Using the information from the different cohorts and databases, new and ground-breaking analyses will be developed and realised.”

Project Coordinator, Director of the MRC Dementia Platform UK and Professor of Cognitive Health at the University of Oxford